Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories
Oct 22, 2025
Interested in our Q3 2025 earnings?

Get some key highlights of our performance this quarter.

Oct 21, 2025
Her father walked her down the aisle, thanks to her company's heart device

The WATCHMAN Left Atrial Appendage Closure device has given one employee's family more time to celebrate.

Sep 26, 2025
What is coronary artery disease and how is it treated?

CAD is the most common form of heart disease. Learn why arteries become clogged and how minimally invasive treatments can reopen them.

Read more stories

Press releases
Nov 3, 2025
Boston Scientific announces upcoming investor conference schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On November 18, 2025, Kenneth Stein, M.D., senior vice president and global chief medical officer,...

Oct 22, 2025
Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis...

Oct 17, 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced...

Read more press releases

In the news
Oct 14, 2025
A breakthrough for blocked arteries
The Wall Street Journal (sponsored)
Read how the AGENT™ Drug Coated Balloon — now available in the U.S. — addresses a critical unmet need for in-stent restenosis (ISR) treatment, using tech that represents a “quantum leap” forward.
Aug 6, 2025
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures
MassDevice
A recent survey highlights that women are seeking new ways to lose weight, as Boston Scientific launches Endura Weight Loss Solutions to increase awareness of minimally invasive weight loss procedures.
Jun 30, 2025
3 ways AI is delivering for unmet cardiology needs
STAT (sponsored)
At STAT’s AI-focused Breakthrough Summit West, Ken Stein, MD, senior vice president and global chief medical officer, shares how artificial intelligence is helping cardiologists make the leap from available insights to actionable ones.
Jun 12, 2025
What's the secret behind Boston Scientific's successful product launches?
BioWorld
At DeviceTalks Minnesota, Ken Stein, MD, senior vice president and global chief medical officer, outlines the steps Boston Scientific takes to evaluate a market, choose a development approach and establish the groundwork for adoption.

Read more news

How AI is already transforming your health care
2024 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

News alerts

Sign up to receive our press releases via email

Media contacts

Business and enterprise contacts for journalists

Media resources

Imagery and other resources

Top